Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD
Go back to Liquidia Provides Update on Clinical Pipeline Targeting PAH and PH-ILD| (NASDAQ: LQDA) | Delayed: 74.33 -3.37 (4.34%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $77.70 | 52 Week High | $ | |||
| Open | $76.20 | 52 Week Low | $ | |||
| Day High | $76.77 | P/E | N/A | |||
| Day Low | $72.83 | EPS | $ | |||
| Volume | 1,447,550 | |||||
